Kkalpana Industries India Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 30, 2026

Key Highlights

The Latest Trading Price of KKalpana Industries (India) Ltd is ₹ 7.95 as of 17 Feb 15:30 . The P/E Ratio of KKalpana Industries (India) Ltd changed from 8.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of KKalpana Industries (India) Ltd changed from ₹ 205.55 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of KKalpana Industries (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of KKalpana Industries (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of KKalpana Industries (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of KKalpana Industries (India) Ltd changed from 8.39 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About KKalpana Industries (India) Ltd

Kalapana industries (India) Ltd was incorporated in September, 1985.
In priority, the Company was engaged in the business of manufacturing of PVC & XLPE Compounds and Embroidery of Fabrics.
Post Amalgamation, the Company recycles plastic and manufactures plastic granules.
It has 2 manufacturing units with state-of-the-art machinery, infrastructure, equipment, and R&D facilities.
With plants located at East Coast of India, the Company gains advantage of low freight costs. The company chalked out an expansion project at a cost of Rs.5 crores to increase the production capacities of XLPE. The commercial production is expected during the financial year of 2003-04. The Scheme of Amalgamation of KaIpana Plastics Pvt Ltd (KPPL) with the Company was made effective on 14 November, 2005.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of KKalpana Industries (India) Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, KKalpana Industries (India) Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of KKalpana Industries (India) Ltd is 209 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,576 Cr

What are the key factors driving the stock performance of KKalpana Industries (India) Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of KKalpana Industries (India) Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KKalpana Industries (India) Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 30, 2026, the KKalpana Industries (India) Ltd stock price is INR ₹22.25. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1101.5.

How do dividend payouts of KKalpana Industries (India) Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of KKalpana Industries (India) Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.